Corporates
LogoName Σ
Kurma Partners Kurma Partners

Our Vision : We have High Standards - We Build Companies - We have Impact Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2). Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and Medtech

Sectors: Startup accelerator & VC

81 58 20
France Biotech France Biotech

Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: …

Sectors: Biotechnology Startup accelerator & VC

585 344 370
BFM Business BFM Business

[Automatic translation follows] First economic and financial information channel in France. BFM Business TV is the leading economic and financial news channel in France. It is distinguished by programming centered on the search for expertise. Programs on economic news have established themselves as economic news events. “Good Morning Business” for example, offers on its guest set the latest innovations, editorials and information on underlying trends. BFM Business TV is also available live on our website as well as on an application dedicated to it. Tech, Stock Market, Economy, Real Estate, Business, Automobile, and High-Tech

Sectors: Media

4145 3629 504
Bpifrance Bpifrance

[Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies, from start-up to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region adapted to each stage of the life of companies. As a partner bank for entrepreneurs, Bpifrance supports them over the long term to support their growth and competitiveness. The teams are at the heart of the regions, throughout the territory, through more than 50 regional locations. Financing SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee

Sectors: Bank

9498 7447 1141
Hello Tomorrow Hello Tomorrow

Building a collaborative ecosystem that leverages the power of deep technologies to tackle world challenges. Hello Tomorrow was created in 2011 by a group of individuals convinced that science and technology need to form part of a toolkit of solutions to change our industries, sustain a growing population and help solve global crises. But the traditional model of technology transfer to bring solutions from lab to market, and from idea to impact, could not rise to this challenge. In turn, Hello Tomorrow has built, and now animates, a global ecosystem that facilitates ‘deep tech’ innovation through multiple activities. Over the …

Sectors: Trade show

425 294 153
Novartis Novartis

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy

Sectors: Pharmaceutical

595 499 52